Abstract
Background Intracellular DNA vaccine delivery is essential for antigen expression and induction of immune response. Unfortunately, conventional intramuscular injection provides low efficiency DNA uptake and suboptimal immunogenicity. Electroporation-based DNA vaccination can enhance potency by 100-1000 fold. In this trial we used the TriGrid Delivery System by Ichor Medical Systems. We describe the electroporation technical errors that occurred during administration of an HIV pDNA vaccine in a clinical trial conducted at sites in Rwanda and Uganda and how those errors were resolved.
Highlights
Intracellular DNA vaccine delivery is essential for antigen expression and induction of immune response
Electroporation (EP)-related technical errors experienced during an HIV vaccine clinical trial conducted in Rwanda and Uganda: lessons learned
We describe the electroporation technical errors that occurred during administration of an HIV pDNA vaccine in a clinical trial conducted at sites in Rwanda and Uganda and how those errors were resolved
Summary
Intracellular DNA vaccine delivery is essential for antigen expression and induction of immune response. Conventional intramuscular injection provides low efficiency DNA uptake and suboptimal immunogenicity. Electroporation-based DNA vaccination can enhance potency by 100-1000 fold. In this trial we used the TriGrid Delivery System by Ichor Medical Systems. We describe the electroporation technical errors that occurred during administration of an HIV pDNA vaccine in a clinical trial conducted at sites in Rwanda and Uganda and how those errors were resolved
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.